Electromed Newsroom


Electromed, Inc. Launches SmartVest Connect Wireless Technology for SmartVest® SQL®

New Prague, Minnesota – July 19, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced the late June launch of the SmartVest® SQL® with SmartVest Connect wireless technology, a personalized high frequency chest wall oscillation (HFCWO) therapy management portal for patients with compromised pulmonary function. Read the Press Release


Electromed, Inc. Announces Poster Presentation at the 2017 World Bronchiectasis Conference

New Prague, Minnesota – June 29, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced that an abstract highlighting the results of a retrospective case review study comparing exacerbation rates before and after high frequency chest wall oscillation (HFCWO) has been accepted for a scientific poster presentation at the World Bronchiectasis Conference, taking place from July 6 – 8, 2017 in Milan, Italy. Read the Press Release


Electromed, Inc. Schedules Release of Third Quarter Fiscal 2017 Financial Results and Conference Call

New Prague, Minnesota – April 26, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced that it will issue its financial results press release for the fiscal 2017 third quarter ended March 31, 2017 on Monday, May 15, 2017 after the close of the stock market. Management will host a conference call on Tuesday, May 16, 2017 at 9:00 a.m. Eastern Time to discuss the results.  Read the Press Release


Electromed, Inc. To Distribute Aerobika® OPEP Device

New Prague, Minnesota – February 21, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced entry into an agreement with Monaghan Medical Corporation to distribute and sell the Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Device in the United States homecare market. Electromed will begin sales of the Aerobika® OPEP device in targeted geographies in the third quarter of its fiscal 2017, with planned expansion prior to the end of the fiscal year. Read the Press Release


Electromed, Inc. Announces Results of Cost-Effective Analysis of Using HFCWO in Patients with Non-Cystic Fibrosis Bronchiectasis

New Prague, Minnesota – February 1, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced that a new study published in Respiratory Therapy: The Journal of Pulmonary Technique shows that consistent use of the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related healthcare utilization and cost. In total, the results revealed an annual savings of $3,045 per bronchiectasis patient, per year of SmartVest use.  Read the Press Release


Electromed, Inc. Schedules Release of Second Quarter Fiscal 2017 Financial Results and Conference Call

New Prague, Minnesota – January 25, 2017 – Electromed, Inc. (NYSE MKT: ELMD) today announced that it will issue its financial results press release for the fiscal 2017 second quarter ended December 31, 2016 on Tuesday, February 7, 2017 after the close of the stock market.  Management will host a conference call on Wednesday, February 8, 2017 at 9:00 a.m. Eastern Time to discuss the results.  Read the Press Release


Electromed, Inc. To Participate in the Benchmark Micro Cap Discovery Conference on December 1, 2016

New Prague, Minnesota – November 21, 2016 – Electromed, Inc. (NYSE MKT: ELMD) today announced that Electromed’s Chief Executive Officer, Kathleen Skarvan, and Chief Financial Officer, Jeremy Brock, will conduct one-on-one meetings with investors at the Benchmark Company Micro Cap Discovery Conference on Thursday, December 1, 2016 at The Palmer House Hilton in Chicago. Read the Press Release


Electromed, Inc. Introduces Expanded SmartVest® Garment and SmartVest SQL® Generator Colors to Product Line

New Prague, Minnesota – October 26, 2016 – Electromed, Inc. (NYSE MKT: ELMD) today announced the expansion of its SmartVest SQL Airway Clearance System product line to include new SmartVest garment and SQL generator colors, offering patients with chronic impaired airway clearance more opportunities to personalize their HFCWO therapy experience. Read the Press Release


Electromed, Inc. Schedules Release of First Quarter Fiscal 2017 Financial Results and Conference Call

New Prague, Minnesota – October 25, 2016 – Electromed, Inc. (NYSE MKT: ELMD) today announced that it will issue its financial results press release for the fiscal 2017 first quarter ended September 30, 2016 on Tuesday, November 8, 2016 after the close of the stock market. Management will host a conference call on Wednesday, November 9, 2016 at 9:00 a.m. Eastern Time to discuss the results. Read the Press Release


Electromed, Inc. Set to Join Russell Microcap Index

New Prague, Minnesota – June 21, 2016 – Electromed, Inc. (NYSE MKT: ELMD) today announced that, according to a preliminary list of additions posted on June 10, 2016, Electromed expects to join the Russell Microcap® Index at the conclusion of the annual reconstitution of the Index on June 24, 2016. Listing as a member, which remains in place for one year, will be effective after the U.S. market opens on June 27, 2016. Read the Press Release


Electromed, Inc. Names John Kowalczyk Vice President of Sales

New Prague, Minnesota – February 29, 2016 – Electromed, Inc. (NYSE MKT: ELMD), maker of the SmartVest® Airway Clearance System, today announced that John Kowalczyk has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives. Read the Press Release


Electromed, Inc. Announces Launch of SmartVest® SQL® System for Acute Care HFCWO Therapy

New Prague, Minnesota – June 17, 2015 – Electromed, Inc. (NYSE MKT: ELMD) today announced the U.S. market launch of its next generation SmartVest Airway Clearance System for acute care high frequency chest wall oscillation (HFCWO), the model SQL-I. Read the Press Release


One-on-One with Kathleen Skarvan, Electromed CEO

New Prague, Minnesota – March 16, 2015 – Electromed, Inc. President and CEO Kathleen Skarvan sits down with The Wall Street Transcript to discuss high frequency chest wall oscillation (HFCWO), the SmartVest Airway Clearance System, corporate revenues and Electromed’s continued focus on improving the quality of patients’ lives. Read the Transcript


Video: Insights for families living with cystic fibrosis

New Prague, Minnesota – November 12, 2014 – Author, speaker and certified family life educator Lisa Greene provides valuable insights for families living with cystic fibrosis. See how her family weaves airway clearance therapy into their daily routine. Watch the Video


Electromed, Inc. Reports a Profit on Higher Fiscal 2014 Fourth Quarter Revenues

New Prague, Minnesota – September 23, 2014 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for its fourth quarter and fiscal year ended June 30, 2014. Read the Press Release


Electromed, Inc. Names Lee Jones to its Board of Directors

August 26, 2014 — Electromed, Inc. (NYSE MKT: ELMD), announced today that its Board of Directors has elected Lee Jones to the Board. Ms. Jones has served as the President and Chief Executive Officer of Rebiotix Inc. since 2011 and as a director of Uroplasty, Inc. since 2006. Read the Press Release


Electromed, Inc. Board Member Announces Plans to Step Down from Board

May 22, 2014 – Electromed, Inc. (NYSE MKT: ELMD) announced today that Darrel Kloeckner, a member of the Company’s Board of Directors will not stand for reelection at the Company’s 2014 Annual Meeting of Shareholders. Mr. Kloeckner has been a member of the Board since 2010. Read the Press Release


Electromed, Inc. Reports Higher Fiscal 2014 Third Quarter Results

May 13, 2014 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2014. Net revenues in the third quarter of fiscal 2014 were approximately $3.96 million, an approximately 24% increase compared to the same period of fiscal 2013.  Read the Press Release


Electromed, Inc. Announces Book Promotion

May 5, 2014 – Electromed, Inc. (NYSE MKT: ELMD) has joined Healthy Choices, Happy Kids in the launch of its new children’s book, which explores the magic of choices and consequences. While supplies last, newly prescribed patients ages 10 and under will receive a free copy of the book with their SmartVest® shipment. Read the Press Release


Electromed, Inc. Reports Fiscal Year 2014 Second Quarter Results

February 11, 2014 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the Company’s second quarter of fiscal 2014. Net revenues in the quarter were approximately $3.50 million, a 9% decrease compared to $3.86 million in the same period of fiscal 2013. Read the Press Release


Electromed, Inc. announces hiring of Vice President of Sales

January 27, 2014 – Electromed, Inc. (NYSE MKT: ELMD) maker of the SmartVest® Airway Clearance System, today announced that Mike Weatherly has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives. Read the Press Release


Electromed, Inc. receives FDA Market Clearance for the SmartVest® SQL

December 30, 2013 – Electromed, Inc. (NYSE MKT: ELMD) today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest® Airway Clearance System, the model SQLhas been cleared to market. Read the Press Release


Electromed, Inc. Reports Fiscal Year 2014 First Quarter Results

November 12, 2013 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30, 2013. Net revenues in the first quarterof fiscal 2014 were approximately $3.4 million, a 15% decrease compared to the same period of fiscal 2013. Read the Press Release


Electromed, Inc. Announces Investor Open House

October 30, 2013 – Electromed, Inc. (NYSE MKT: ELMD) will hold an investor open house on Wednesday, November 6. Read the Press Release


Electromed, Inc. Reports Fiscal Year 2013 Fourth Quarter and Year-End Results

September 25, 2013 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the 2103 fourth quarter and fiscal year, ended June 30, 2013. Net revenues for the fiscal 2013 fourth quarter were $4.0 million, compared with net revenues of $4.6 million for the same period last year. Net revenues for fiscal 2013 totaled $15.1 million, compared to $19.5 million for the previous year.  Read the Press Release


Electromed, Inc. Reports Fiscal Year 2013 Third Quarter Results

May 14, 2013 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2013. Net revenues for the three months ended March 31, 2013, were approximately $3,199,000, a 33.0% decrease compared to net revenues of approximately $4,774,000 for the same period last year.
Read the Press Release


Electromed, Inc. Makes Minneapolis/St. Paul Business Journal’s Top 100 for Third Year

April 5, 2013 – Electromed, Inc. (NYSE MKT: ELMD) maker of the SmartVest® Airway Clearance System, has been ranked as one of the 100 largest publicly traded companies in Minnesota by the Minneapolis/St. Paul Business Journal for the third year in a row, according to the list published March 29, 2013.
Read the Press Release


Electromed, Inc. Introduces Ginkgo Green to Product Line 

April 1, 2013 – Electromed, Inc. (NYSE MKT: ELMD) maker of the SmartVest® Airway Clearance System today announced the expansion of its product line with Ginkgo Green, a new SmartVest garment color.
Read the Press Release


Electromed, Inc. Reports Fiscal Year 2013 Second Quarter Results

February 13, 2013 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended December 31, 2012. Net revenues for the three months ended December 31, 2012, were approximately $3,856,000, a 19.5% decrease compared to net revenues of approximately $4,790,000 for the same period last year.
Read the Press Release


Electromed, Inc. Announces Appointment of Kathleen Skarvan as Chief Executive Officer

November 29, 2012 – The Board of Directors of Electromed, Inc. announced today that Kathleen Skarvan has been appointed as the Company’s Chief Executive Officer, effective December 1, 2012. Ms. Skarvan succeeds Dr. James J. Cassidy, who has served as the Company’s interim CEO since May 2012. Dr. Cassidy will continue to serve as Chief Operating Officer of the Company.
Read the Press Release


Electromed, Inc. Reports Fiscal Year 2013 First Quarter Results

November 13, 2012 – Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30, 2012. Net revenues for the three months ended September 30, 2012 were approximately $4,031,000, a 25.1% decrease compared to net revenues of approximately $5,379,000 for the same period last year.
Read the Press Release


Electromed, Inc. Reports 2012 Fourth–Quarter and Year–End Results

September 24, 2012 – Electromed, Inc. (NYSE MKT: ELMD), today announced financial results for the 2012 fourth quarter and fiscal year, ended June 30, 2012. Net revenues for the fiscal 2012 fourth quarter were $4.6 million, compared with net revenues of $5.0 million for the same period last year. Net loss for the quarter was $179,000, or ($0.02) per diluted share, compared to net income of approximately $165,000, or $0.02 per diluted share, for the comparable fiscal 2011 period.
Read the Press Release


Electromed, Inc. Reports 2012 Third Quarter Results

May 15, 2012 – Electromed, Inc. (NYSE Amex: ELMD) today announced financial results for the three-month period ended March 31, 2012. Management indicated that, while the Company’s Sales Team provided an increase in the number of prescriptions for the SmartVest® Airway Clearance System versus the prior year quarter, actual revenue has been negatively impacted by certain reimbursement factors. Among these factors are diagnoses that are not assured of reimbursement and insurance programs with lower allowable reimbursement amounts.
Read the Earnings Release


Electromed, Inc. Chairman and CEO Robert D. Hansen Announces His Retirement After 20 Years; Board Appoints Dr. James J. Cassidy as Interim Chief Executive Officer

May 14, 2012 – Robert D. Hansen, Founder, CEO, and Chairman of the Board of Electromed, Inc., today announced his retirement after twenty years. In May of 1992, Hansen and his brother Craig Hansen first began work on the SmartVest® Airway Clearance System, an innovative High Frequency Chest Wall Oscillation (HFCWO) device in Minneapolis, Minnesota. Their first United States product sale occurred in 2001, with the first international sale in 2006, followed by initial sales in Asia in 2008. Hansen has led the company through successive generations of the product. By June 30, 2011, the Company had grown to over $19 million in sales and was employing more than 90 employees across the United States. The Company also engages on a contract services basis more than 300 certified Respiratory Therapists and Nurses who educate patients on the use of the SmartVest® Airway Clearance System.
Read the Press Release


Electromed, Inc. Once Again Makes Minneapolis/St. Paul Business Journal’s Top 100 Public Companies List

April 05, 2012 – Electromed, Inc. (NYSE Amex: ELMD), maker of the SmartVest® Airway Clearance System, has been once again ranked as one of the 100 largest publicly traded companies in Minnesota by the Minneapolis/St. Paul Business Journal. The publication’s “Top 100 Public Companies” lists Minnesota-based companies according to revenue and operating earnings based on the most recent four quarters, without regard to fiscal year end. Electromed, Inc. was ranked #89, up from #98 in 2011, among Minnesota-based public companies with $20.3 million in Calendar Year 2011 revenue, an increase of 22% from Calendar Year 2010 revenue.
Read the Press Release


Electromed, Inc. Reports 2012 Second Quarter Results

February 14, 2012 – Electromed, Inc. (NYSE Amex: ELMD) today announced financial results for the three-month period ended December 31, 2011. Net Revenues for the three months ended December 31, 2011, were approximately $4,790,000, a 2.2% increase compared to Net Revenues of approximately $4,686,000 for the same period last year. The Company also announced Net Income of approximately $25,000, or $0.00 per basic and diluted share, for the three months ended December 31, 2011, compared to Net Income of approximately $292,000, or $0.03 per basic and diluted share, for the same period last year. The reduction in Net Income results was attributable to missed sales goals reflecting underperformance by a number of former Clinical Area Managers. This resulted from termination-driven turnover of approximately 16% of the sales force. Management continues to believe that planned increases in the Company’s sales force, reimbursement and production personnel, coupled with the expansion of marketing and research and development efforts, will provide strong impetus for continued solid annual sales growth.
Read the Earnings Release


Electromed, Inc. Partners with Leader Healthcare FCZO to Distribute the SmartVest® Airway Clearance System in the GCC Region

January 11, 2012 – Electromed, Inc. (NYSE Amex: ELMD), has announced an exclusive partnership with Leader Healthcare FZCO for sale and distribution of its flagship product, the SmartVest® Airway Clearance System. Leader Healthcare FZCO, headquartered in Dubai, caters to the Specialty Healthcare needs of the Medical Fraternity in the GCC (Gulf Cooperation Council) Region (United Arab Emirates (UAE), Saudi Arabia, Kuwait, Qatar, Oman, and Bahrain) and represents a significant number of product lines in multiple health care fields.
Read the Press Release


Electromed, Inc. Provides Guidance Regarding Operating Performance for the Fiscal Quarter and Last Half of 2012 Fiscal Year

January 17, 2012 – After reporting a strong First Quarter FY2012 ended September 30, 2011, in which Sales advanced 29% versus the comparable prior Fiscal Year Quarter, Electromed, Inc. (NYSE Amex: ELMD) announces the following actions that will impact operating performance for its Second Quarter ended December 31, 2011 and the Second Half of FY2012 ending June 30, 2012.
Read the Press Release

 

<<View More Newsroom